Lv4
450 积分 2025-09-11 加入
Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Time-Dependent Analysis of Reconstructed Individual Patient Data From the PEACE-3 Trial
4天前
已完结
Patient Preference of Apalutamide Versus Enzalutamide for Recurrent or Metastatic Hormone-sensitive Prostate Cancer: An Open-label, Randomized, Crossover Trial
4天前
已完结
The efficacy and safety of enzalutamide in metastatic hormone-sensitive prostate cancer: a meta-analysis based on subgroups and reconstructed individual patient data
4天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
Long-term Clinical Outcomes and Optimal Treatment Approaches of Degenerative Cervical Spondylosis: A 12-Year Multicenter Retrospective Cohort Study
1个月前
已完结
Health-related quality of life, pain, and symptomatic skeletal events with [¹⁷⁷Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
1个月前
已完结
Effect of shenfu injection in patients with septic shock: A systemic review and meta-analysis for randomized clinical trials
1个月前
已完结
Shenfu Injection Ameliorates Sepsis - Associated Acute Kidney Injury via Inhibiting Inflammatory Response and Oxidative Stress: A Randomized Controlled Trial
1个月前
已关闭
Shenfu injection ameliorates endotoxemia-associated endothelial dysfunction and organ injury via inhibiting PI3K/Akt-mediated glycolysis
1个月前
已完结
Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer
2个月前
已完结
皖公网安备34019202002308
